FAIRFAX, Va.--(BUSINESS WIRE)--Vibrent Health today announced that it has been selected to provide the technology platform for the groundbreaking Precision Medicine Initiative (PMI) research program led by the White House. This landmark longitudinal initiative aims to engage one million or more U.S. participants as partners to improve the ability to prevent and treat diseases based on individual differences in lifestyle, environment and genetics.
The PMI Program is one of the most ambitious projects in history and will set the foundation for new ways to enable “patient-powered medicine.” PMI volunteers will be asked to contribute a wide range of health, environment and lifestyle information. They will also be invited to answer questions about their health history and status, share their genomic and other biological information through simple blood and fluid tests and grant access to their clinical data from electronic health records. In addition, mobile health devices and apps will provide lifestyle data and environmental exposures in real time. All of this will be protected using highest standards in federal data security such as FedRAMP and implementation guidelines for privacy, trust and consent. The participants will have access to a wide range of their individual data and insights as well as to aggregated results.
Volunteers will enroll, consent and donate their data through Vibrent Health’s technology platform using mobile apps, web interfaces, interactive voice response (IVR), feature phones and wearable sensors. Vibrent Health will develop, test, maintain and upgrade the technology platform over a period of five years for the term of the award using state of the art and secure data hosting from AWS GovCloud. NIH aims to begin enrolling participants later this year and has set a goal of reaching one million volunteers within four to five years and hopes to continue to enroll participants well beyond that mark.
“This $74 million funding over five years is one of the largest federal investments in a health technology platform of its kind and we are honored to be selected for this mission-critical initiative,” said Vibrent Health founder and CEO Praduman Jain. “It validates our platform and demonstrates customer confidence in our technology innovation, security and maturity.”
The Vibrent Health ‘personalization engine’ is a central component of the platform that will tailor precise experiences and data collection methods to meet the unique needs of every individual. The intention is to catalyze a revolution in how to prevent, detect and treat diseases with a level of precision that is not possible without the large and diverse dataset that the PMI research program will generate.
"This is the most far-reaching medical research initiative in the history of the United States,” said Eric Topol, Director of the Scripps Translational Science Institute. “So for us at Scripps to get to work again with Praduman Jain and his remarkably talented team at Vibrent Health, we’re set up for a truly exciting and transformative collaboration.”
Vibrent Health has partnered with The Scripps Research Institute (TSRI), which will drive engagement research, participant enrollment of direct volunteers over five years and validation of emerging wearables and medical devices.
Vibrent has also partnered with CSC who will provide an important element of human touch that complements the technology approach to data donation. CSC will provide participant support for consent, engagement, retention outreach and technical support. “As a physician, for my patients and profession, I am excited to partner with Vibrent Heath on this groundbreaking Precision Medicine Initiative that will advance healthcare discoveries and improve health,” said Dr. Robert Wah, Global Chief Medical Officer at CSC.
Vibrent Health looks forward to enabling other large scale implementations for advocacy, clinical research, public health, global health, clinical care and medical device organizations using the Vibrent Health Precision Medicine Platform.
President Obama Quote
“Precision medicine gives us the chance to marry what’s unique about America — our spirit of innovation, our courage to take risks, our collaborative instincts – with what’s unique about Americans – every individual’s distinctive genetic makeup, lifestyles, and health needs. In doing so, we can keep ourselves, our families, and our nation healthier for generations to come,” said President Barack Obama in an op-ed for the Boston Globe.
NIH Director Francis S. Collins Quote
“This range of information at the scale of one million people from all walks of life will be an unprecedented resource to understand all of the factors that influence health and disease,” said NIH Director Francis S. Collins, M.D., Ph.D. “Over time, data provided by participants will help us answer important health questions, such as why some people with elevated genetic and environmental risk factors for disease still manage to maintain good health, and how people suffering from a chronic illness can maintain the highest possible quality of life. The more we understand about individual differences, the better able we will be to effectively prevent and treat illness.”
For more information on the Precision Medicine Initiative (PMI), see https://www.whitehouse.gov/precision-medicine. For more information on the PMI Cohort Program, see https://www.nih.gov/precision-medicine-initiative-cohort-program
About Vibrent Health
Vibrent Health provides an evidence-based B2B2C technology infrastructure called ‘Adaptive Platform for Precision Engagement’ that enables longitudinal data collection, engagement and insights. This infrastructure is supported by the three pillars of technology, science and customer support, each of which continuously improves through a process of “measure-learn-iterate”. Such an approach enables adaptability and personalization to ensure long-term success of population level programs. To learn more visit: http://www.vibrenthealth.com/